U.S. Agrees To $231M Deal For At-Home Test Kits

The Biden administration has secured a $231 million deal with an Australian company to produce rapid COVID-19 test kits that allow home testing with results in 20 minutes. These tests, recently approved by US regulators, are the only ones available without a prescription. The ability to quickly test, trace, and quarantine is crucial to the national strategy for containing the virus. The company plans to use the funds to establish a US manufacturing plant and deliver 8.5 million tests for federal use, although no specific timeline has been provided.

What is the significance of the ability to quickly test in the context of the national strategy?

What will Aloom do with the money from the deal?